MFS
KYMR icon

Mirabella Financial Services’s Kymera Therapeutics KYMR Stock Holding History

Mirabella Financial Services’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,132
Closed -$489K – 402
2020
Q3 		$489K Buy
+15,132
New +$462K 0.07% 142

Other funds holding KYMR

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DIC
Deer IX & Co Larchmont, New York $971M AUM 24.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mirabella Financial Services's KYMR Position: Q4 2020 in Review

Mirabella Financial Services sold out of Kymera Therapeutics (KYMR) in Q4 2020, closing a stake of 15,132 shares — an estimated $489K sold.

Mirabella Financial Services first reported a position in KYMR in Q3 2020 and held it in 1 quarter. The position peaked at $489K in Q3 2020. 75 funds tracked by Wall St. Rank hold KYMR as of Q4 2020.

  • Mirabella Financial Services reported no remaining Kymera Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Mirabella Financial Services sold 15,132 Kymera Therapeutics shares in Q4 2020, an estimated $489K.
  • Mirabella Financial Services first reported a position in Kymera Therapeutics in Q3 2020 and held it in 1 quarter.
  • Mirabella Financial Services's Kymera Therapeutics position peaked at $489K in Q3 2020.
  • 75 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q4 2020.

Based on Mirabella Financial Services's 13F filing for Q4 2020, filed 16 Feb 2021.